Chawla Lakhmir S 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Jul 1, 2020
Insider Transaction Report
Form 4
Chawla Lakhmir S
Chief Medical Officer
Transactions
- Award
Common Stock
2020-06-30$3.62/sh+543$1,966→ 10,920 total - Award
Employee Stock Option (Right to Buy)
2020-06-30+543→ 543 totalExercise: $4.26Exp: 2030-06-30→ Common Stock (543 underlying)
Footnotes (2)
- [F1]These shares were acquired on 06/30/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vest and become exercisable ratably on a monthly basis over the next three years.